510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K991597Substantially Equivalent

Cobas Integra Amikacin Mab

Roche Diagnostics GmbH, Indianapolis IN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K991597 is the FDA 510(k) clearance record for COBAS INTEGRA AMIKACIN MAB, a class II device, cleared for Roche Diagnostics Corp. on under FDA product code LGJ (Fluorescence Polarization Immunoassay, Amibacin). FDA records list 465 510(k) clearances for Roche Diagnostics Corp., from to . As of , FDA records show no recalls naming K991597.

Clearance record

Decision date
Received
(73 days to decision)
Product code
LGJ Fluorescence Polarization Immunoassay, Amibacin
Regulation
21 CFR 862.3035
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Roche Diagnostics Corp. 9115 Hague Rd., P.O. Box 50457, Indianapolis IN
510(k) summary
Summary
Third party review
No

Clearances, product code LGJ

Trailing 12 months

FDA records hold no clearances under product code LGJ in the trailing twelve months.

FDA records show no clearances under product code LGJ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LGJ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260